Índice

• • ·EDB

    Página :i

    

• Reviews

  • ·Use of insulin in type 2 diabetes: What we learned from recent clinical trials on the benefits of early insulin initiation

    Página :391-399

    M. Hanefeld

    Resumen Resumen Esquema Esquema   
  • ·Molecular mechanisms of GLUT4 regulation in adipocytes

    Página :400-410

    R. Govers

    Resumen Resumen Esquema Esquema   
  • ·Incretin-based therapy and pancreatic beta cells

    Página :411-422

    S. Chon, J.-P. Riveline, B. Blondeau, J.-F. Gautier

    Resumen Resumen Esquema Esquema   

• Original articles

  • ·Association between metabolically unhealthy overweight/obesity and chronic kidney disease: The role of inflammation

    Página :423-430

    S. Chen, S. Zhou, B. Wu, Y. Zhao, X. Liu, Y. Liang, X. Shao, H. Holthöfer, H. Zou

    Resumen Resumen Esquema Esquema   
  • ·Insights from a thermography-based method suggesting higher carotid inflammation in patients with diabetes mellitus and coronary artery disease

    Página :431-438

    K. Toutouzas, G. Benetos, M. Drakopoulou, P. Bounas, D. Tsekoura, K. Stathogiannis, I. Koutagiar, C. Aggeli, A. Karanasos, D. Panagiotakos, E. Siores, C. Stefanadis

    Resumen Resumen Esquema Esquema   
  • ·Serum sex steroids and steroidogenesis-related enzyme expression in skeletal muscle during experimental weight gain in men

    Página :439-444

    K. Sato, D. Samocha-Bonet, D.J. Handelsman, S. Fujita, G.A. Wittert, L.K. Heilbronn

    Resumen Resumen Esquema Esquema   
  • ·Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy

    Página :445-451

    F. Semeraro, A. Cancarini, F. Morescalchi, M.R. Romano, R. dell’Omo, G. Ruggeri, L. Agnifili, C. Costagliola

    Resumen Resumen Esquema Esquema   
  • ·Association of endothelial lipase Thr111Ile polymorphism with proliferative retinopathy in type 2 diabetes patients

    Página :452-458

    C. Arndt, I. Leclercq, P. Nazeyrollas, A. Durlach, A. Ducasse, I. Movesayan, E. Socquard, C. Clavel, M.M. Malloy, C.R. Pullinger, J.P. Kane, V. Durlach

    Resumen Resumen Esquema Esquema  
  • ·Clinical utility of serum beta-2-microglobulin as a predictor of diabetic complications in patients with type 2 diabetes without renal impairment

    Página :459-465

    M.K. Kim, K.-J. Yun, H.J. Chun, E.-H. Jang, K.-D. Han, Y.-M. Park, K.-H. Baek, K.-H. Song, B.-Y. Cha, C.S. Park, H.-S. Kwon

    Resumen Resumen Esquema Esquema   
  • ·Perceived psychosocial stress and glucose intolerance among pregnant Hispanic women

    Página :466-475

    M.L. Silveira, B.W. Whitcomb, P. Pekow, B. Braun, G. Markenson, N. Dole, J.E. Manson, C.G. Solomon, E.T. Carbone, L. Chasan-Taber

    Resumen Resumen Esquema Esquema  

• Short report

  • ·Polymerase chain reaction–denaturing gradient gel electrophoresis (PCR–DGGE): A promising tool to diagnose bacterial infections in diabetic foot ulcers

    Página :476-480

    C. Dunyach-Remy, A. Cadière, J.-L. Richard, S. Schuldiner, S. Bayle, B. Roig, A. Sotto, J.-P. Lavigne

    Resumen Resumen Esquema Esquema   

• Letters to the editor

  • ·Switching from insulin glargine to insulin degludec reduced HbA_1c, daily insulin doses and anti-insulin antibody in anti-insulin antibody-positive subjects with type 1 diabetes

    Página :481-482

    H. Hamasaki, H. Yanai

    Resumen Resumen Esquema Esquema
  • ·Acylated-based long-acting insulin analogues: Is “misfolding” the problem? Commentary letter on Hamasaki H and Yanai H. The switching from insulin glargine to insulin degludec reduced HbA_1c, daily insulin doses and anti-insulin antibody in anti-insulin antibody-positive subjects with type 1 diabetes

    Página :483-484

    L. Monnier, C. Colette, D. Owens

    Resumen Resumen Esquema Esquema